Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30001788HIVENSG00000148680.16protein_codingHTR7NoNo3363P34969
TVIS30081632HIVENSG00000148680.16protein_codingHTR7NoNo3363P34969
TVIS20006328HPVENSG00000148680.16protein_codingHTR7NoNo3363P34969
TVIS20033320HPVENSG00000148680.16protein_codingHTR7NoNo3363P34969
TVIS20048781HPVENSG00000148680.16protein_codingHTR7NoNo3363P34969
TVIS20036895HPVENSG00000148680.16protein_codingHTR7NoNo3363P34969
TVIS20041222HPVENSG00000148680.16protein_codingHTR7NoNo3363P34969
TVIS44004709HTLV-1ENSG00000148680.16protein_codingHTR7NoNo3363P34969
TCGA Plot Options
Drug Information
GeneHTR7
DrugBank IDDB00589
Drug NameLisuride
Target IDBE0000650
UniProt IDP34969
Regulation Type
PubMed IDs18996971; 19509219
CitationsKnight JA, Smith C, Toohey N, Klein MT, Teitler M: Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists. Mol Pharmacol. 2009 Feb;75(2):374-80. doi: 10.1124/mol.108.052084. Epub 2008 Nov 7.@@Toohey N, Klein MT, Knight J, Smith C, Teitler M: Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists". Mol Pharmacol. 2009 Sep;76(3):552-9. doi: 10.1124/mol.109.056283. Epub 2009 Jun 9.
GroupsApproved; Investigational
Direct ClassificationIndoloquinolines
SMILES[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Pathways
PharmGKBPA164749019
ChEMBLCHEMBL157138